Search Results: immunotherapy

• Health & Medicine

How will new cancer medicines be approved in the future?

In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed? In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?

2 December 2021

• For Supporters
• Policy & Insight

“Supporting research is mission critical for me and always will be” – Philanthropy award winners share their stories

Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.   Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.  

29 November 2021

• Health & Medicine

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England. Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

25 November 2021

• Health & Medicine

Three cancer drugs approved for NHS use in Scotland

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

11 November 2021

• For Supporters

On legacy giving: “It allows me to give something more meaningful than I could in my lifetime”

Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will. Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will.

13 October 2021

• Health & Medicine

Cancer in children and young people: how far we’ve come

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers. Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers.

29 September 2021

• For Researchers
• Health & Medicine

Making the most of your ‘eureka’ moment: getting from the science to the clinic

How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset

22 September 2021

• Health & Medicine

New chemotherapy-free treatment for bowel cancer made available in Scotland

Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.   Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.  

14 September 2021

• Health & Medicine

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer. The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

10 September 2021

• For Researchers

Kinder and more effective - why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

3 September 2021

• Health & Medicine
• Science & Technology

Cancer Research UK reports record levels of investment in its spinouts

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

24 August 2021

• Health & Medicine
• Science & Technology

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

13 August 2021